Receipt of a stimulant prescription for attention-deficit/hyperactivity disorder (ADHD) via telehealth is not associated with an increased risk for substance use disorder (SUD).

Many physicians would personally prefer to avoid life-sustaining practices if they had advanced cancer or Alzheimer disease.

For adults with obesity or overweight without diabetes, the novel cyclic adenosine monophosphate-biased glucagon like peptide 1 receptor agonist, ecnoglutide, yields a superior and sustained reduction ...